Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis. J of Skin [Internet]. 2023 Nov. 13 [cited 2025 Apr. 10];7(6):s251. Available from: https://skin.dermsquared.com/skin/article/view/2398